Skip to main content

ARDELYX, INC.

For the period ended Aug 6, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Aug 6, 2026 · Filed Aug 6, 2026

Use the contents to explore the available documents and sections.

ARDX$2.88-3.7%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Corporate Developments

Corporate Developments

On June 29, 2026, the Company drew $50 million from its existing financing arrangement with SLR Investment Corp. for general corporate purposes and to enhance flexibility to support its ongoing strategic initiatives in line with its capital allocation strategy.

On June 26, 2026, the U.S. Court of Appeals for the D.C. Circuit affirmed the district court’s dismissal of our lawsuit against CMS related to CMS reimbursement classification of XPHOZAH and we will not pursue further litigation on this matter.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.